Targeting the Eukaryotic Translation Initiation Factor 4E for Cancer Therapy
Open Access
- 1 February 2008
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (3), 631-634
- https://doi.org/10.1158/0008-5472.can-07-5635
Abstract
The eukaryotic translation initiation factor 4E (eIF4E) is frequently overexpressed in human cancers in relation to disease progression and drives cellular transformation, tumorigenesis, and metastatic progression in experimental models. Enhanced eIF4E function results from eIF4E overexpression and/or activation of the ras and phosphatidylinositol 3-kinase/AKT pathways and selectively increases the translation of key mRNAs involved in tumor growth, angiogenesis, and cell survival. Consequently, by simultaneously and selectively reducing the expression of numerous potent growth and survival factors critical for malignancy, targeting eIF4E for inhibition may provide an attractive therapy for many different tumor types. Recent work has now shown the plausibility of therapeutically targeting eIF4E and has resulted in the advance of the first eIF4E-specific therapy to clinical trials. These studies illustrate the increased susceptibility of tumor tissues to eIF4E inhibition and support the notion that the enhanced eIF4E function common to many tumor types may represent an Achilles' heel for cancer. [Cancer Res 2008;68(3):631–4]Keywords
This publication has 18 references indexed in Scilit:
- Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicityJCI Insight, 2007
- RNA-Mediated Sequestration of the RNA Helicase eIF4A by Pateamine A Inhibits Translation InitiationCell Chemical Biology, 2006
- A Phase I Pharmacokinetic and Pharmacodynamic Study of OGX-011, a 2′-Methoxyethyl Antisense Oligonucleotide to Clusterin, in Patients With Localized Prostate CancerJNCI Journal of the National Cancer Institute, 2005
- Translation Initiation Factor 4E Blocks Endoplasmic Reticulum-mediated ApoptosisPublished by Elsevier BV ,2004
- Survival signalling by Akt and eIF4E in oncogenesis and cancer therapyNature, 2004
- Addiction to Oncogenes--the Achilles Heal of CancerScience, 2002
- Reduction of translation initiation factor 4E decreases the malignancy of ras ‐transformed cloned rat embryo fibroblastsInternational Journal of Cancer, 1995
- Decreasing the level of translation initiation factor 4E with antisense rna causes reversal of ras‐mediated transformation and tumorigenesis of cloned rat embryo fibroblastsInternational Journal of Cancer, 1993
- Ras mediates translation initiation factor 4E-induced malignant transformation.Genes & Development, 1992
- Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' capNature, 1990